{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:33:06Z","timestamp":1744504386212},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/bf03346452","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T22:05:32Z","timestamp":1396044332000},"page":"196-201","source":"Crossref","is-referenced-by-count":11,"title":["The relationship among renal injury, changed activity of renal 1-\u03b1 hydroxylase and bone loss in elderly rats with insulin resistance or Type 2 diabetes mellitus"],"prefix":"10.1007","volume":"32","author":[{"given":"C. Q.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Z.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q. X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346452_CR1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","volume":"55","author":"AI Parvanova","year":"2006","unstructured":"Parvanova AI, Trevisan R, Iliev IP, et al. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 2006, 55: 1456\u201362.","journal-title":"Diabetes"},{"key":"BF03346452_CR2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1097\/01.ASN.0000015762.92814.85","volume":"13","author":"CM Hoehner","year":"2002","unstructured":"Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002, 13: 1626\u201334.","journal-title":"The Inter-Tribal Heart Project. J Am Soc Nephrol"},{"key":"BF03346452_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1291\/hypres.25.271","volume":"25","author":"M Mizuno","year":"2002","unstructured":"Mizuno M, Sada T, Kato M, Koike H. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertens Res 2002, 25: 271\u20138.","journal-title":"Hypertens Res"},{"key":"BF03346452_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diab.41.11.1422","volume":"41","author":"K Kawano","year":"1992","unstructured":"Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992, 41: 1422\u20138.","journal-title":"Diabetes"},{"key":"BF03346452_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0344-0338(80)80051-3","volume":"167","author":"R Bader","year":"1980","unstructured":"Bader R, Bader H, Grund KE, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 1980, 167: 204\u201316.","journal-title":"Pathol Res Pract"},{"key":"BF03346452_CR6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","volume":"56","author":"RE Gilbert","year":"1999","unstructured":"Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999, 56: 1627\u201337.","journal-title":"Kidney Int"},{"key":"BF03346452_CR7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1755.1998.00079.x","volume":"54","author":"KA Nath","year":"1998","unstructured":"Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998, 54: 992\u20134.","journal-title":"Kidney Int"},{"key":"BF03346452_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","volume":"20","author":"KA Nath","year":"1992","unstructured":"Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992, 20: 1\u201317.","journal-title":"Am J Kidney Dis"},{"key":"BF03346452_CR9","first-page":"50","volume":"45","author":"A Ortiz","year":"1997","unstructured":"Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997, 45: 50\u20136.","journal-title":"J Investig Med"},{"key":"BF03346452_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-1755.2000.07710.x","volume":"77","author":"G Wolf","year":"2000","unstructured":"Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000, 77: 59\u201366.","journal-title":"Kidney Int Suppl"},{"key":"BF03346452_CR11","first-page":"S10","volume":"54","author":"FN Ziyadeh","year":"1996","unstructured":"Ziyadeh FN. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int Suppl 1996, 54: S10\u20133.","journal-title":"Kidney Int Suppl"},{"key":"BF03346452_CR12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.V7122495","volume":"7","author":"AA Eddy","year":"1999","unstructured":"Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1999, 7: 2495\u2013508.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346452_CR13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1440-1681.1997.tb02130.x","volume":"24","author":"ME Cooper","year":"1997","unstructured":"Cooper ME, Gilbert RE, Jerums G. Diabetic vascular complications. Clin Exp Pharmacol Physiol 1997, 24: 770\u20135.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF03346452_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(98)01346-4","volume":"352","author":"ME Cooper","year":"1998","unstructured":"Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998, 352: 213\u20139.","journal-title":"Lancet"},{"key":"BF03346452_CR15","first-page":"S101","volume":"47","author":"M Yaqoob","year":"1994","unstructured":"Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, Bell GM. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Kidney Int Suppl 1994, 47: S101\u20134.","journal-title":"Kidney Int Suppl"},{"key":"BF03346452_CR16","first-page":"601","volume":"87","author":"M Yaqoob","year":"1994","unstructured":"Yaqoob M, McClelland P, Patrick AW, et al. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 1994, 87: 601\u20137.","journal-title":"QJM"},{"key":"BF03346452_CR17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1993.95","volume":"43","author":"PH Lane","year":"1993","unstructured":"Lane PH, Steffes MW, Fioretto P, Mauer SM. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993, 43: 661\u20137.","journal-title":"Kidney Int"},{"key":"BF03346452_CR18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1464-5491.1999.00174.x","volume":"16","author":"SC Jones","year":"1999","unstructured":"Jones SC, Saunders HJ, Pollock CA. High glucose increases growth andcollagen synthesis in cultured human tubulointerstitial cells. Diabet Med 1999, 16: 932\u20138.","journal-title":"Diabet Med"},{"key":"BF03346452_CR19","first-page":"S191","volume":"63","author":"M Ueno","year":"1997","unstructured":"Ueno M, Kawashima S, Nishi S, et al. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int Suppl 1997, 63: S191\u20134.","journal-title":"Kidney Int Suppl"},{"key":"BF03346452_CR20","first-page":"265","volume":"66","author":"N Marcussen","year":"1992","unstructured":"Marcussen N. Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 1992, 66: 265\u201384.","journal-title":"Lab Invest"},{"key":"BF03346452_CR21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diab.43.8.1046","volume":"43","author":"JL Taft","year":"1994","unstructured":"Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FI. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 1994, 43: 1046\u201351.","journal-title":"Diabetes"},{"key":"BF03346452_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/clinchem\/39.3.517","volume":"39","author":"J Holm","year":"1993","unstructured":"Holm J, Hemmingsen L, Nielsen NV. Low-molecular-mass proteinuria as a marker of proximal renal tubular dysfunction in normo- and microalbuminuric non-insulin-dependent diabetic subjects. Clin Chem 1993, 39: 517\u20139.","journal-title":"Clin Chem"},{"key":"BF03346452_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1056-8727(97)00045-7","volume":"12","author":"CY Hong","year":"1998","unstructured":"Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998, 12: 43\u201360.","journal-title":"J Diabetes Complications"},{"key":"BF03346452_CR24","first-page":"377","volume":"9","author":"GD Nuyts","year":"1994","unstructured":"Nuyts GD, Yaqoob M, Nouwen EJ, et al. Human urinary intestinal alkaline phosphatase as an indicator of S3-segment-specific alterations in incipient diabetic nephropathy. Nephrol Dial Transplant 1994, 9: 377\u201381.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03346452_CR25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/BF00180026","volume":"71","author":"S Pfleiderer","year":"1993","unstructured":"Pfleiderer S, Zimmerhackl LB, Kinne R, et al. Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall protein. Clin Investig 1993, 71: 972\u20137.","journal-title":"Clin Investig"},{"key":"BF03346452_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1681\/ASN.V34947","volume":"3","author":"CH Hsu","year":"1992","unstructured":"Hsu CH, Patel S. Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol 1992, 3: 947\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"BF03346452_CR27","doi-asserted-by":"crossref","first-page":"E840","DOI":"10.1152\/ajpcell.1992.262.4.C840","volume":"262","author":"B Lobaugh","year":"1992","unstructured":"Lobaugh B, Boass A, Garner SC, et al. Intensity of lactation modulates renal 1 alpha-hydroxylase and serum 1,25(OH)2D in rats. Am J Physiol 1992, 262: E840\u20134.","journal-title":"Am J Physiol"},{"key":"BF03346452_CR28","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1126\/science.141098","volume":"196","author":"LE Schneider","year":"1977","unstructured":"Schneider LE, Schedl HP, McCain T, Haussler MR. Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science 1977, 196: 1452\u20134.","journal-title":"Science"},{"key":"BF03346452_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0009-9120(99)00085-5","volume":"33","author":"H Aksoy","year":"2000","unstructured":"Aksoy H, Ak\u00e7ay F, Kurtul N, Baykal O, Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000, 33: 47\u201351.","journal-title":"Clin Biochem"},{"key":"BF03346452_CR30","first-page":"1137","volume":"85","author":"YS Chung","year":"2000","unstructured":"Chung YS, Lee MD, Lee SK, Kim HM, Fitzpatrick LA. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000, 85: 1137\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346452_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0168-8227(94)90126-0","volume":"23","author":"F Gregorio","year":"1994","unstructured":"Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 1994, 23: 43\u201354.","journal-title":"Diabetes Res Clin Pract"},{"key":"BF03346452_CR32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1464-5491.2004.01292.x","volume":"21","author":"A Nakashima","year":"2004","unstructured":"Nakashima A, Nakashima R, Ito T, Masaki T, Yorioka N. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus. Diabetic Med 2004, 21: 1020\u20134.","journal-title":"Diabetic Med"},{"key":"BF03346452_CR33","first-page":"287","volume":"61","author":"M Takizawa","year":"2003","unstructured":"Takizawa M, Kameyama K, Maruyama M, Ishida H. Bone loss in type 2 diabetes mellitus-diabetic osteopenia. Nippon Rinsho 2003, 61: 287\u201391.","journal-title":"Nippon Rinsho"},{"key":"BF03346452_CR34","first-page":"1423","volume":"25","author":"MA Al-Maatouq","year":"2004","unstructured":"Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J 2004, 25: 1423\u20137.","journal-title":"Saudi Med J"},{"key":"BF03346452_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1262-3636(07)70128-3","volume":"30","author":"T Ikeda","year":"2004","unstructured":"Ikeda T, Manabe H, Iwata K. Clinical significance of alendronate in postmenopausal type 2 diabetes mellitus. Diabetes Metab 2004, 30: 355\u20138.","journal-title":"Diabetes Metab"},{"key":"BF03346452_CR36","first-page":"125","volume":"100","author":"J Sieradzki","year":"1998","unstructured":"Sieradzki J, Trznadel-Morawska I, Olszanecki P. Bone density in type 2 diabetes as related to obesity and adrenal function. Pol Arch Med Wewn 1998, 100: 125\u201332.","journal-title":"Pol Arch Med Wewn"},{"key":"BF03346452_CR37","first-page":"299","volume":"140","author":"V Bartos","year":"2001","unstructured":"Bartos V, Jirkovsk\u00e1 A, Kasalick\u00fd P, Smahelov\u00e1 A, Vondra K, Skibov\u00e1 J. Osteopenia and osteoporosis in diabetic women over 40 years of age. Cas Lek Cesk 2001, 140: 299\u2013301.","journal-title":"Cas Lek Cesk"},{"key":"BF03346452_CR38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","volume":"24","author":"KK Nicodemus","year":"2001","unstructured":"Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001, 24: 1192\u20137.","journal-title":"Diabetes Care"},{"key":"BF03346452_CR39","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","volume":"29","author":"M Janghorbani","year":"2006","unstructured":"Janghorbani M, Feskanich D, Willett W, Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses\u2019 Health Study. Diabetes Care 2006, 29: 1573\u20138.","journal-title":"Diabetes Care"},{"key":"BF03346452_CR40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1464-5491.2006.01825a.x","volume":"23","author":"BJ Boucher","year":"2006","unstructured":"Boucher BJ. Hypovitaminosis D and risk of Type 2 diabetes in British South Asians. Diabet Med 2006, 23: 336.","journal-title":"Diabet Med"},{"key":"BF03346452_CR41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00125-005-1802-7","volume":"48","author":"C Mathieu","year":"2005","unstructured":"Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48: 1247\u201357.","journal-title":"Diabetologia"},{"key":"BF03346452_CR42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/BF00265373","volume":"31","author":"P Pietschmann","year":"1988","unstructured":"Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988, 31: 892\u20135.","journal-title":"Diabetologia"},{"key":"BF03346452_CR43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.29.03.06.dc05-1961","volume":"29","author":"AG Pittas","year":"2006","unstructured":"Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29: 650\u20136.","journal-title":"Diabetes Care"},{"key":"BF03346452_CR44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","volume":"57","author":"AM Borissova","year":"2003","unstructured":"Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57: 258\u201361.","journal-title":"Int J Clin Pract"},{"key":"BF03346452_CR45","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK, Bunn RC, et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005, 289: E735\u201345.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF03346452_CR46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02553711","volume":"37","author":"CT Rubin","year":"1985","unstructured":"Rubin CT, Lanyon LE. Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 1985, 37: 411\u20137.","journal-title":"Calcif Tissue Int"},{"key":"BF03346452_CR47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/clinchem\/21.1.119","volume":"21","author":"WJ Blaedel","year":"1975","unstructured":"Blaedel WJ, Uhl JM. Nature of materials in serum that interfere in the glucose oxidase-peroxidase-O-dianisidine method for glucose, and their mode of action. Clin Chem 1975, 21: 119\u201324.","journal-title":"Clin Chem"},{"key":"BF03346452_CR48","first-page":"CR480","volume":"10","author":"M Straczkowski","year":"2004","unstructured":"Straczkowski M, Stepie\u0144 A, Kowalska I, et al. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Med Sci Monit 2004, 10: CR480\u20134.","journal-title":"Med Sci Monit"},{"key":"BF03346452_CR49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/jcp.39.10.1151","volume":"39","author":"GF Watts","year":"1986","unstructured":"Watts GF, Albano JD, Bennett JE, Morris RW, Shaw KM, Polak A. Assessment of new radioimmunoassay kit for determining urinary albumin at low concentrations: comparison with radial immunodiffusion. J Clin Pathol 1986, 39: 1151\u20134.","journal-title":"J Clin Pathol"},{"key":"BF03346452_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01625443","volume":"1","author":"J Lilley","year":"1991","unstructured":"Lilley J, Walters BG, Heath DA, et al. In vivo and in vitro precision for bone density measured by dual-energy X-ray absorption. Osteoporos Int 1991, 1: 141\u20136.","journal-title":"Osteoporos Int"},{"key":"BF03346452_CR51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/jcem-50-1-70","volume":"50","author":"AM Frumar","year":"1980","unstructured":"Frumar AM, Meldrum DR, Geola F, et al. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab 1980, 50: 70\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346452_CR52","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0026-0495(85)90192-1","volume":"34","author":"CC Johnston Jr","year":"1985","unstructured":"Johnston CC Jr, Hui SL, Longcope. Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics. Metabolism 1985, 34: 544\u201350.","journal-title":"Metabolism"},{"key":"BF03346452_CR53","first-page":"E655","volume":"265","author":"IR Reid","year":"1993","unstructured":"Reid IR, Evans MC, Cooper GJ, Ames RW, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 1993, 265: E655\u20139","journal-title":"Am J Physiol"},{"key":"BF03346452_CR54","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/diacare.19.12.1388","volume":"19","author":"E Barrett-Connor","year":"1996","unstructured":"Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care 1996, 19: 1388\u201392.","journal-title":"Diabetes Care"},{"key":"BF03346452_CR55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.200204046","volume":"159","author":"T Akune","year":"2002","unstructured":"Akune T, Ogata N, Hoshi K, et al. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 2002, 159: 147\u201356.","journal-title":"J Cell Biol"},{"key":"BF03346452_CR56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI9017","volume":"105","author":"N Ogata","year":"2000","unstructured":"Ogata N, Chikazu D, Kubota N, et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 2000, 105: 935\u201343.","journal-title":"J Clin Invest"},{"key":"BF03346452_CR57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature01660","volume":"423","author":"S Harada","year":"2003","unstructured":"Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003, 423: 349\u201355.","journal-title":"Nature"},{"key":"BF03346452_CR58","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","volume":"69","author":"PV Hauschka","year":"1989","unstructured":"Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989, 69: 990\u20131047.","journal-title":"Physiol Rev"},{"key":"BF03346452_CR59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130: 456\u201369.","journal-title":"Cell"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346452\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T16:27:11Z","timestamp":1689092831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BF03346452"],"URL":"https:\/\/doi.org\/10.1007\/bf03346452","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}